"It All Depends": A Qualitative Study of Parents' Views of Human Papillomavirus Vaccine for their Adolescents at Ages 11᾿2 years

详细信息    查看全文

• 作者：Caitlin E. Hansen ; Marisol Credle ; Eugene D. Shapiro…
• 关键词：HPV ; HPV vaccine ; Qualitative
• 刊名：Journal of Cancer Education
• 出版年：2016
• 出版时间：March 2016
• 年：2016
• 卷：31
• 期：1
• 页码：147-152
• 全文大小：126 KB
• 参考文献：1.Centers for Disease Control and Prevention (2010) FDA licensure of bivalent human papillomavirus vaccine (HPV2, Cervarix) for use in females and updated HPV vaccination recommendations from the Advisory Committee on Immunization Practices (ACIP). MMWR 59:626–630
  2.Centers for Disease Control and Prevention (CDC) (2011) Recommendations of the use of quadrivalent human papillomavirus vaccine in males—Advisory Committee of Immunization Practices (ACIP), 2011. MMWR 60(50):1705–1708
  3.American Academy of Pediatrics Committee on Infectious Diseases (2012) HPV vaccine recommendations. Pediatrics 129(3):602–605CrossRef
  4.Winer RL, Feng Q, Hughes JP et al (2008) Risk of female human papillomavirus associated with first male sex partner. JID 197:279–282PubMedCentral CrossRef PubMed
  5.Block SL, Nolan T, Sattler C et al (2006) Comparison of the immunogenicity and reactogenicity of a prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in male and female adolescents and young adult women. Pediatrics 118(5):2135–2145CrossRef PubMed
  6.Centers for Disease Control and Prevention (2014) National, regional, state, and selected local area vaccination coverage among adolescents aged 13–17 years, United States, 2013. MMWR 63(29):625–633
  7.Centers for Disease Control and Prevention (2014) Human papillomavirus vaccination coverage among adolescents, 2007–2013, and post licensure vaccine safety monitoring, 2006–2014—United States. MMWR 63(29):620–624
  8.Holman DM, Benard V, Roland KB et al (2014) Barriers to human papillomavirus vaccination among US adolescents: a systematic review of the literature. JAMA Pediatr 168(1):76–82PubMedCentral CrossRef PubMed
  9.Kessels SJ, Marshall HS, Watson M et al (2012) Factors associated with HPV vaccine uptake in teenage girls: a systematic review. Vaccine 30(24):3546–3556CrossRef PubMed
  10.Vadaparampil ST, Kahn JA, Salmon D (2011) Missed clinical opportunities: provider recommendations for HPV vaccination for 11–12 year old girls are limited. Vaccine 29(47):8634–8641PubMedCentral CrossRef PubMed
  11.Daley MF, Crane LA, Markowitz LE et al (2010) Human papillomavirus vaccination practices: a survey of US physicians 18 months after licensure. Pediatrics 126(3):425–433CrossRef PubMed
  12.Hariri S, Markowitz LE, Dunne ED, Unger ER (2013) Population impact of HPV vaccines: summary of early evidence. J Adolesc Health 53:679–682CrossRef PubMed
  13.Niccolai LM, Julian PJ, Bilinski A et al (2013) Area-based poverty, racial, and ethnic disparities in cervical cancer precursor rates in Connecticut, 2008–2009. Am J Public Health 103:156–163PubMedCentral CrossRef PubMed
  14.Centers for Disease Control and Prevention (2014) United States Cancer statistics. http://​apps.​nccd.​cdc.​gov/​uscs/​cancersbyraceand​ethnicity.​aspx . Accessed 14 Feb 2014
  15.Jemal A, Simard EP, Dorell C et al (2013) Annual report to the nation on the status of cancer, 1975–2009, featuring the burden and trends in human papillomavirus (HPV)-associated cancers and HPV vaccination coverage levels. J Nat Cancer Inst 105(3):175–201PubMedCentral CrossRef PubMed
  16.Clarke V, Braun V (2013) Successful qualitative research: a practical guide for beginners. Sage Publications, Los Angeles
  17.Guest G, MacQueen KM, Namey EE (2012) Applied thematic analysis. Sage Publications, Los AngelesCrossRef
  18.Hughes CC, Jones AJ, Feemster KA et al (2011) HPV vaccine decision making in pediatric primary care: a semi-structured interview study. BMC Pediatr 11:74PubMedCentral CrossRef PubMed
  19.Perkins RB, Clark JA, Apti G et al. Missed opportunities for HPV vaccination in adolescent girls: a qualitative study. [published online ahead of print August 18, 2014]. Pediatrics. doi:10.​1542/​peds.​2014-0442
  20.President’s Cancer Panel Annual Report 2012–2013. 2014. Accelerating HPV vaccine uptake: urgency for action to prevent cancer. http://​deainfo.​nci.​nih.​gov/​advisory/​pcp/​annualReports/​HPV/​index.​htm . Accessed 10 Feb 2014
  21.Darden PM, Thompson DM, Roberts JR et al (2013) Reasons for not vaccinating adolescents: national immunization survey of teens, 2008–2010. Pediatrics 131(4):645–651CrossRef PubMed
  22.Dempsey AF, Abraham LM, Dalton V et al (2009) Understanding the reasons why mothers do or do not have their adolescent daughters vaccinated against human papillomavirus. Ann Epidemiol 19(8):531–538PubMedCentral CrossRef PubMed
  23.Liddon N, Michael SM, Dittus P et al (2013) Maternal underestimation of child’s sexual experience: suggested implications for HPV vaccine uptake at recommended ages. J Adolesc Health 53(5):674–676CrossRef PubMed
  24.Kornfeld J, Byrne MM, Vanderpool R et al (2013) HPV knowledge and vaccine acceptability among Hispanic fathers. J Prim Prev 34:59–69PubMedCentral CrossRef PubMed
  
• 作者单位：Caitlin E. Hansen (1)
  Marisol Credle (2) (3)
  Eugene D. Shapiro (1) (4) (5)
  Linda M. Niccolai (2) (3) (4)
  
  1. Department of Pediatrics, Yale School of Medicine, PO Box 208064, New Haven, CT, 06520, USA
  2. Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, USA
  3. Yale Center for Interdisciplinary Research on AIDS, New Haven, CT, USA
  4. Yale Cancer Center, New Haven, CT, USA
  5. Department of Investigative Medicine, Yale Graduate School of Arts and Sciences, New Haven, CT, USA
  
• 刊物主题：Cancer Research; Pharmacology/Toxicology;
• 出版者：Springer US
• ISSN：1543-0154

文摘

Routine vaccination with three doses of human papillomavirus (HPV) vaccine is recommended for adolescent girls and boys at 11 or 12 years of age; however, vaccine uptake remains suboptimal. To understand the reasons why parents may accept or refuse HPV vaccine for their children at age 11 or 12 years, we conducted a qualitative study. Semi-structured interviews were conducted with parents or guardians (n = 45) whose adolescents receive care at an urban, hospital-based primary care practice. Data were analyzed using an iterative thematic approach. We found that many parents expressed high levels of support for HPV vaccine, including a majority who agreed with vaccination at age 11–12 years. Parents recognized that for prevention of consequences of HPV infection, vaccination of their child early in adolescence was desirable conceptually. However, many parents also expressed that in practice, HPV vaccine should be given to adolescents at the onset of sexual activity, a perception that led to preferences to delay administration of HPV vaccine among certain parents. These apparently contradictory views indicate the need for interventions focused on the benefits of vaccination at the recommended ages. Our findings may be useful in providers’ discussions with parents about the vaccine, as pediatric and adolescent health care providers have the unique opportunity to educate parents and clarify misconceptions about vaccination.